The content on this site is intended for healthcare professionals only
Addition of panitumumab can lead to an increased survival in colorectal cancer p...
Prof Salvatore Siena - Niguarda Ca' Granda Hospital, Milan
20 Apr 2010
FOLFIRI plus panitumumab can lead to an increased PFS in colorectal cancer patie...
Dr Thierry Andre - Hopital Tenon, Paris, France
20 Apr 2010
Advances in TME surgery
Prof Cornelis van de Velde - Leiden University Medical Center, the Netherlands
19 Apr 2010
Total Mesorectal Excision
Prof Bill Heald OBE - Pelican Cancer Foundation, UK
19 Apr 2010
Progress made by the Dutch Colorectal Cancer Group and key issues emerging from ...
Prof Cornelis Punt - Radboud University and Nijmegen Medical Centre, the Netherl...
19 Apr 2010
Metastatic colorectal cancer management
Dr Richard Goldberg - University of North Carolina, USA
14 Apr 2010
Problem areas and concluding advice - Molecular Pathology Education Module 4
Professor Giuseppe Viale - European Institute of Oncology
17 Feb 2010
HER 2: Interpretation of ICH and FISH Assays - Molecular Pathology Education Mod...
Professor Giuseppe Viale - European Institute of Oncology
17 Feb 2010
Tips on HER2 Assays - Molecular Pathology Education Module 2
Professor Giuseppe Viale - European Institute of Oncology
17 Feb 2010
How to test for HER2, the lessons and pitfalls - Molecular Pathology Education M...
Professor Giuseppe Viale - European Institute of Oncology
17 Feb 2010
Colorectal cancer incidence in Africa
Dr Otis Brawley - Chief Medical Officer, American Cancer Society
6 Jan 2010
Advances in the use of antibodies
Prof Martin Glennie, Director of Cancer Sciences, University of Southampton, UK
20 Nov 2009
